.
.
.
.
Coronavirus

Coronavirus: Pfizer COVID-19 vaccine could get UK approval this week

Published: Updated:

Britain could give regulatory approval to Pfizer-BioNTech’s COVID-19 vaccine this week, even before the US authorizes it, the Telegraph news site reported on Sunday.

Citing government sources, it said British regulators were about to start a formal appraisal of the vaccine, made by Pfizer Inc and BioNTech SE, and that the National Health Service had been told to be ready to administer it by Dec. 1.

For more coronavirus news, visit our dedicated page.

The US Food and Drug Administration said on Friday that it would meet on Dec. 10 to discuss whether to authorize the vaccine.

Britain formally asked its medical regulator, the MHRA, last week to assess the suitability of the Pfizer-BioNTech vaccine.

Britain has ordered 40 million doses and expects to have 10 million doses, enough to protect 5 million people, available by the end of the year if regulators approve it.

Read more:

Coronavirus: US drug authority set to meet next month to discuss COVID-19 vaccine

G20 leaders commit to fair distribution of coronavirus vaccines worldwide: Statement

Coronavirus: Moderna to charge $25-$37 for COVID-19 vaccine, CEO says